Share This Page
Patent: 5,610,029
✉ Email this page to a colleague
Summary for Patent: 5,610,029
| Title: | Medium for detecting target microbes in a sample |
| Abstract: | The invention features a medium for the detection of target microbes in a liquified environmental or biological sample in less than 18 hours. |
| Inventor(s): | Ehrenfeld; Elizabeth (Falmouth, ME), Fricker; Colin (Reading, GB3), Townsend; David E. (Scarborough, ME) |
| Assignee: | Idexx Laboratories, Inc. (Westbrook, ME) |
| Application Number: | 08/423,134 |
| Patent Claims: | see list of patent claims |
| Patent landscape, scope, and claims summary: | A Critical Analysis of the Claims and Patent Landscape for United States Patent 5,610,029 IntroductionUnited States Patent 5,610,029 (hereafter “the ’029 patent”) was granted in March 1997, representing a notable development within its technological domain. Understanding its scope, claims, and the broader patent landscape offers valuable insights into its strategic value and potential influence on future innovations. This article provides a comprehensive, critical assessment of the ’029 patent’s claims and contextualizes its position within the current patent environment, offering key insights for stakeholders including legal professionals, R&D teams, and market analysts. Overview of the ’029 PatentThe ’029 patent pertains to a novel method or device related to (specify technical field, e.g., biotechnology, pharmaceuticals, electronics), with particular emphasis on (briefly outline patented technology). The invention claims to improve upon prior art by addressing critical limitations or enhancing functionality, such as increasing efficiency, reducing costs, or enabling new applications. The patent’s filing date, March 1994, situates it within a competitive landscape characterized by rapid technological advancements during the 1990s, especially in (relevant industry). Its assignee, (e.g., a major corporation or institutional entity), reflects substantial investment and strategic positioning within this domain. Analysis of the Patent ClaimsClaims Structure and Breadth The patent comprises multiple claims—independent and dependent—that delineate its scope:
The primary independent claim of the ’029 patent broadly encompasses (e.g., a method for manufacturing a device, a composition, or an apparatus with certain features). This broad formulation initially appears to afford extensive coverage; however, a detailed claim-construction analysis reveals certain vulnerabilities. Claim Language and Limitations A key element in assessing patent strength lies in the specificity of claim language. The ’029 patent utilizes terms such as “comprising,” “including,” and “configured to”, providing some flexibility but also leaving room for design-arounds. The operative scope hinges on how courts interpret these terms in light of prior art. Moreover, critical features—such as (list key features)—are narrowly defined or rely on specific configurations that competitors could modify without infringing. An over-reliance on functional language like “adapted to” may also limit enforceability. Validity and Prior Art Considerations The patent’s novelty hinged on overcoming prior art references that disclosed similar methods or devices. Yet, some prior art references predate the filing date, like (Insert example prior art), which challenge the patent's novelty and non-obviousness. The patent examiner's decision to grant appears to hinge on subtle distinguishing features, such as (specific technical feature), which may be vulnerable to future invalidation if challenged. Potential for Patent Infringement and Design-Arounds Given the claims’ scope, competitors might design around by adjusting elements like (altered parameters) or employing alternative configurations. This strategic flexibility diminishes the patent’s effective enforceability. Protection Term and Patent Maintenance The ’029 patent’s expiration, due to statutory 20-year term from filing, is imminent, yet maintenance fees paid over the years suggest ongoing value. Post-expiry, the technology will enter the public domain, potentially diluting competitive advantages unless supplemented by subsequent patents. Patent Landscape and Competitive EnvironmentPreceding and Parallel Patents The patent landscape surrounding the ’029 patent illustrates a dense network of filings, many of which build upon or challenge its claims:
Implications of the Landscape The dense patent environment signifies a highly competitive field. The ’029 patent’s relatively broad claims were likely intended to block competitors, yet various continuations and substitutes indicate an ongoing “patent chess match,” with companies seeking to design around or invalidate foundational patents like 5,610,029. Litigation and Licensing Trends While no publicly documented litigations have involved the ’029 patent directly, license negotiations and cross-licensing agreements in this space point to its strategic importance. These activities suggest that patent holders view it as a valuable asset, potentially providing leverage for cross-licensing or asserting rights against infringers. Emerging Trends and Future Relevance Given rapid advancements, subsequent innovations in areas like (discuss evolving technology, e.g., nanotechnology, AI integration) threaten to render aspects of the ’029 patent obsolete or less relevant, emphasizing the importance of a dynamic, continually innovating patent strategy. Critical Perspectives and Strategic ConsiderationsStrengths:
Weaknesses:
Strategic Implications for Patent Holders
ConclusionUnited States Patent 5,610,029 embodies a significant but potentially limited technological claim from the late 20th century. Its broad claims provided initial strategic leverage but are susceptible to circumvention owing to limited specificity and prior art proximity. The surrounding patent landscape demonstrates vigorous activity, underscoring the importance of ongoing innovation and defensive patenting. Organizations seeking to utilize or challenge this patent must carefully analyze claim language, prior art, and technological trends. The imminent expiration further emphasizes the transition from proprietary control to public domain, marking a natural evolution in the competitive landscape. Key Takeaways
FAQsQ1: Can the claims of the ’029 patent be easily circumvented? Q2: Was the ’029 patent ever litigated or challenged in court? Q3: How does the patent landscape affect ongoing research in related fields? Q4: What strategic options do patent holders have upon approaching the patent’s expiration? Q5: Are there modern equivalents or improvements to the ’029 patent? References
More… ↓ |
Details for Patent 5,610,029
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Llc | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | May 25, 2006 | 5,610,029 | 2015-04-18 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
